Low prevalence of human T-lymphotrophic virus type i (HTLV-I) in HIV-positive patients in Kenya
Songok, E.M.; Tukei, P.M.; Libondo, D.; Gichogo, A.; Oogo, S.A.
Journal of Acquired Immune Deficiency Syndromes 7(8): 876-877
1994
ISSN/ISBN: 0894-9255 PMID: 8021826 Document Number: 284753
Document emailed within 1 workday
Related Documents
Songok, E.M.; Tukei, P.M.; Libondo, D.; Gichogo, A.; Oogo, S.A. 1994: Low prevalence of human T-lymphotrophic virus type i (HTLV-I) in HIV-positive patients in Kenya Journal of Acquired Immune Deficiency Syndromes 7(8): 876-877Kawanishi, T.; Itamura, S.; Saida, T.; Kameyama, M.; Hatanaka, M. 1987: Prevalence and immunological properties of antibodies reactive with human T lymphotropic virus type i (HTLV-I) in sera from multiple sclerosis patients Rinsho Shinkeigaku 27(8): 963-968
Takeoka, H.; Furusyo, N.; Toyoda, K.; Murata, M.; Sagara, Y.; Kashiwagi, S.; Hayashi, J. 2007: Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1 American Journal of Tropical Medicine and Hygiene 77(1): 192-196
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Verdier, M.; Denis, F.; Sangaré, A.; Barin, F.; Gershy-Damet, G.; Rey, J.L.; Soro, B.; Léonard, G.; Mounier, M.; Hugon, J. 1989: Prevalence of antibody to human T cell leukemia virus type 1 (HTLV-1) in populations of Ivory Coast, West Africa Journal of Infectious Diseases 160(3): 363-370
Ikeda, K.; Inaba, N.; Takamizawa, H. 1993: Vertical transmission human T-cell lymphotropic virus type-i (HTLV-I)--genetic diagnosis and assessment of the probable routes of HTLV-i infection Nihon Sanka Fujinka Gakkai Zasshi 45(11): 1283-1288
Nicholson, J.K.; Cross, G.D.; Callaway, C.S.; McDougal, J.S. 1986: In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) Journal of Immunology 137(1): 323-329
Varella, R.B.ão.; Ferreira, S.B.ía.; Castro, M.ár.B.d.; Tavares, M.D.; Zalis, M.G. 2008: Prevalence of resistance-associated mutations in human immunodeficiency virus type 1-positive individuals failing HAART in Rio de Janeiro, Brazil Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 12(5): 380-384
Yamada, H.; Nakao, Y.; Fujita, T. 1991: Inhibition of cellular proliferation in human T lyophotropic virus type I (HTLV-I)-infected T cells from patients with HAM by steroid hormones and cyclosporin A Kobe Journal of Medical Sciences 37(2): 57-79
Miwa, M.; Shimotohno, K.; Hoshino, H.; Fujino, M.; Sugimura, T. 1984: Detection of pX proteins in human T-cell leukemia virus (HTLV)-infected cells by using antibody against peptide deduced from sequences of X-IV DNA of HTLV-i and Xc DNA of HTLV-Ii proviruses Gan 75(9): 752-755
Aida, Y.; Amanuma, H.; Okada, K. 1994: Identification of tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma cells and expression of its human homologue in human T-cell lymphotrophic virus I-infected cell lines Leukemia 8(Suppl): S231-S234
Wong-Staal, F.; Shaw, G.M.; Hahn, B.H.; Salahuddin, S.Z.; Popovic, M.; Markham, P.; Redfield, R.; Gallo, R.C. 1985: Genomic diversity of human T-lymphotropic virus type III (HTLV-III) Science 229(4715): 759-762
Lefrère, J.J. 2000: Human T-lymphotropic virus type i (HTLV-I): risk of transmission with transfusion Presse Medicale 29(20): 1134-1138
Hrusková-Heidingsfeldová, O.; Bláha, I.; Urban, J.; Strop, P.; Pichová, I. 1997: Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase Leukemia 11(Suppl 3): 45-46
Stewart, G.J.; Tyler, J.P.; Cunningham, A.L.; Barr, J.A.; Driscoll, G.L.; Gold, J.; Lamont, B.J. 1985: Transmission of human T-cell lymphotropic virus type IIi (HTLV-III) by artificial insemination by donor Lancet 2(8455): 581-585
Nakao, K.; Isashiki, Y.; Uto, M.; Ohba, N.; Kawano, K. 1994: Antibodies to human T-cell lymphotropic virus type 1 in the aqueous humor of HTLV-I associated uveitis Nippon Ganka Gakkai Zasshi 98(9): 866-871
Kilim, Y.; Rosenblatt, J.D.; Danon, Y.L. 1994: Sequence analysis of the new human T cell leukemia/lymphoma virus type i isolate (HTLV-I) in Israel Israel Journal of Medical Sciences 30(12): 891-894
van Gorkom, J.; Kibuga, D.K. 1996: Cost-effectiveness and total costs of three alternative strategies for the prevention and management of severe skin reactions attributable to thiacetazone in the treatment of Human Immunodeficiency Virus positive patients with tuberculosis in Kenya Tubercle and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 77(1): 30-36
De Vuyst, H.; Mugo, N.R.; Chung, M.H.; McKenzie, K.P.; Nyongesa-Malava, E.; Tenet, V.; Njoroge, J.W.; Sakr, S.R.; Meijer, C.M.; Snijders, P.J.F.; Rana, F.S.; Franceschi, S. 2012: Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya British Journal of Cancer 107(9): 1624-1630